about
Meningococcal B Vaccination (4CMenB) in Infants and ToddlersHexavalent vaccines for immunization in paediatric ageAn open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediImpact of pandemic A/H1N1/2009 influenza on children and their families: comparison with seasonal A/H1N1 and A/H3N2 influenza viruses.Antibody response of healthy children to pandemic A/H1N1/2009 influenza virusAntibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project.Evaluation of pituitary function after infectious meningitis in childhood.Genetic polymorphisms and risk of recurrent wheezing in pediatric ageClinical profile of recurrent community-acquired pneumonia in children.Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine.Epidemiology and Clinical Characteristics of Respiratory Infections Due to Adenovirus in Children Living in Milan, Italy, during 2013 and 2014Children with recurrent pneumonia and non-cystic fibrosis bronchiectasisThe impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.Fever and Pain Management in Childhood: Healthcare Providers' and Parents' Adherence to Current RecommendationsRespiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy.Vaccine-preventable diseases: from paediatric to adult targets.Obesity: impact of infections and response to vaccines.Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice.Enterovirus-D68 in the Cerebrospinal Fluid of Two Children with Aseptic Meningitis.Impact of genetic polymorphisms on paediatric atopic dermatitis.Mycoplasma pneumoniae pericarditis and cardiac tamponade in a 7-year-old girl with cystic fibrosis.Clinical and socio-economic impact of influenza and respiratory syncytial virus infection on healthy children and their households.Clinical manifestations and socio-economic impact of influenza among healthy children in the community.Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses.Knowledge of oxygen administration, aerosol medicine, and chest physiotherapy among pediatric healthcare workers in Italy.Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia.Impact of rhinoviruses on pediatric community-acquired pneumonia.Impact of human coronavirus infections in otherwise healthy children who attended an emergency department.Association between high nasopharyngeal viral load and disease severity in children with human metapneumovirus infectionImmunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infantsLevofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhoodComparison of nasopharyngeal nylon flocked swabs with universal transport medium and rayon-bud swabs with a sponge reservoir of viral transport medium in the diagnosis of paediatric influenzaSerum Concentrations of Pneumococcal Anticapsular Antibodies in Children with Pneumonia Associated with Streptococcus pneumonia Infection
P50
Q26782285-91ADD032-B4D0-453A-8105-8DA228882AE6Q26861351-E127C2AC-CB53-4262-95A7-653D87C1BC50Q30395254-FDF72AC0-63B4-404C-A990-BD82AA9CECAAQ30405925-47ECAE0E-A531-48B2-85DB-D2FA18D5DFEEQ30411205-6E790F9A-C0D0-493B-B68E-9A34873A2DA8Q31096335-A13DFC35-D5A2-4248-9F36-758D4DF70DFFQ34333706-5D1B4CF4-C62C-4C8B-AF24-188D9EE37CDCQ34409774-CDBD5807-F661-476C-8D55-BD75DC1BF272Q35012402-FC872796-5BDD-42E0-9E5B-884501FC2BA8Q35890971-86770079-8076-4645-B574-45FC54BC5C47Q35979683-7D33C39E-4756-4BEF-B1C3-A73D35FD7021Q36566061-73FE6578-0495-473C-8286-09BE8CC91306Q36924030-5D14F939-D5F1-4A56-B6D3-7E1825EC1F15Q36937999-CBC8C9BD-C310-46E8-9A7F-1EB0428CD2A4Q36946801-9D0B89EB-7166-49FC-832A-C16C2D0F0EA3Q37862053-82C1BCCE-5D4B-4F30-829B-3C83CEB073EDQ38175773-44D49B26-B07C-409B-99CB-5F561F8744F6Q38683577-CE419BA1-C1D8-41B2-8130-C4DFA2E8F7ADQ39655682-81A7A631-02A9-4689-816D-53507532C9FEQ40798796-A2A1B4D3-A61A-4FD1-88C3-7CE5C57BA621Q41628313-11B47975-99A5-436D-BBC3-04D6DD700042Q43766619-D5E3404C-0827-4847-BB1D-95970832906FQ44621188-5C2275F3-7B14-42DC-BFC1-DEFAD148D4B7Q46606837-0D0D2D85-0A00-444F-9BD0-D29C3D5777F5Q49239889-DF668AEF-8FF3-44A4-916C-98FB0815FF35Q51159776-B5DAA0AB-68AA-4DD0-BEDC-C1CF3AAF5C17Q51527596-10110AFA-B3BF-49CF-9415-0E1228476DF0Q54336610-C6F547DC-9641-4467-A659-6B25113E0A56Q54574647-21E44457-4AF4-4AE0-8BC3-9386D340D90AQ56880133-0A05BC6E-6D59-4A8A-8BD8-B13861A4268AQ57745658-380D05A9-FB14-4A6D-8F5F-A511BBB4B107Q59396657-68BD216D-47C2-49E2-ABE5-C40A6752ECADQ59396735-A90624B6-019D-42E3-A84D-959A5153DB78Q59397405-2054E1E3-442D-47BF-90D5-0E05F0A3ECCC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claudia Tagliabue
@ast
Claudia Tagliabue
@en
Claudia Tagliabue
@es
Claudia Tagliabue
@nl
Claudia Tagliabue
@sl
type
label
Claudia Tagliabue
@ast
Claudia Tagliabue
@en
Claudia Tagliabue
@es
Claudia Tagliabue
@nl
Claudia Tagliabue
@sl
prefLabel
Claudia Tagliabue
@ast
Claudia Tagliabue
@en
Claudia Tagliabue
@es
Claudia Tagliabue
@nl
Claudia Tagliabue
@sl
P1053
K-2706-2016
P106
P21
P31
P3829
P496
0000-0003-0293-933X